Pharma reps meet Star Wars stardom

A long time ago in an imaginary galaxy far, far away, Merck was training an elite squad of Vioxx reps--the V squad--to overcome obstacles to the painkiller's success. Could they beat the futuristic "obstaclizer" and meet their sales goals? See the videos to find out. Report

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.